World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

INVESTIGATING AND RANKING OF BARRIERS AFFECTING DEVELOPMENT OF PHARMACEUTICAL INDUSTRY EXPORTS IN IRAN AHP METHOD

Negar Habibi Naeini and *Ramin Radmanesh

ABSTRACT

Background: Iran's pharmaceutical industry has experienced an average growth rate of 28.38% over the past 10 years. The value of domestically produced drugs is $ 1.639 billion, while imported products are worth $ 0.828 billion over the same period. In addition, the Iranian pharmaceutical industry has seen many changes in recent years; Manufacturers work in an increasingly demanding environment and have no incentive to sell and improve quality due to lack of competition. Materials and Methods: Research method were applied and descriptive; the statistical population was all pharmaceutical organizations export to other countries and the statistical sample of the research consisted of business managers, professors working in the field of export and marketing managers of exporting pharmaceutical companies. Data analysis was performed through hierarchical analysis and decision tree model. Results: The barrier of market characteristics of the destination country with a relative weight of 0.283 is the most important; Therefore, among the obstacles affecting the development of pharmaceutical industry exports in Iran has the highest priority and the obstacle of supply chain of production inputs, value chain of products and distribution with a relative weight of 0.195 is the next priority, other obstacles are geographical, managerial knowledge. Conclusion: suggested that by creating contracts with universities and knowledge-based companies in this field, the problems of up-to-date technology in the world can be solved. On the other hand, by participating in domestic and international conferences in the field of up-to-date knowledge and a kind of knowledge frontier of the world, the necessary planning can be done to localize and close contracts with prominent companies. By establishing diplomatic relations with the Ministry of Foreign Affairs and concluding legal contracts with high precision to avoid the sanctions, it is possible to act with the help of the best lawyers. On the other hand, with the increase of deep economic ties with independent countries in foreign policies in the field of export of these products, the necessary planning should be done.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR